Scarica l'app Stockscreener
13.25
3.71%
-0.51
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$13.76
Aprire:
$13.76
Volume 24 ore:
2.34M
Relative Volume:
3.11
Capitalizzazione di mercato:
$913.29M
Reddito:
$46.02M
Utile/perdita netta:
$-70.80M
Rapporto P/E:
-7.2802
EPS:
-1.82
Flusso di cassa netto:
$-1.61M
1 W Prestazione:
-0.75%
1M Prestazione:
+20.02%
6M Prestazione:
+114.05%
1 anno Prestazione:
+44.34%
Intervallo 1D:
$13.04
$13.77
Intervallo di 1 settimana:
$12.88
$14.14
Portata 52W:
$3.91
$14.42
Eyepoint Pharmaceuticals Inc Stock (EYPT) Company Profile
Nome
Eyepoint Pharmaceuticals Inc
Settore
Industria
Telefono
617-926-5000
Indirizzo
480 PLEASANT STREET, WATERTOWN, MA
Confronta EYPT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EYPT
Eyepoint Pharmaceuticals Inc
|
13.25 | 948.44M | 46.02M | -70.80M | -1.61M | -1.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Eyepoint Pharmaceuticals Inc Stock (EYPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-17 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-01-07 | Iniziato | Citigroup | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-08-28 | Iniziato | Jefferies | Buy |
| 2024-01-22 | Iniziato | JP Morgan | Overweight |
| 2023-11-02 | Iniziato | Mizuho | Buy |
| 2023-04-21 | Iniziato | Robert W. Baird | Outperform |
| 2022-07-07 | Iniziato | Chardan Capital Markets | Buy |
| 2021-03-01 | Iniziato | Cowen | Outperform |
| 2021-01-28 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-04-06 | Downgrade | B. Riley FBR | Buy → Neutral |
| 2019-11-04 | Ripresa | Laidlaw | Buy |
| 2019-09-12 | Iniziato | Guggenheim | Buy |
Mostra tutto
Eyepoint Pharmaceuticals Inc Borsa (EYPT) Ultime notizie
Death Cross: What are analysts price targets for EyePoint Pharmaceuticals IncTrade Exit Summary & Reliable Price Action Trade Plans - khodrobank.com
Sentiment Review: Can EyePoint Pharmaceuticals Inc. outperform under higher oil pricesPortfolio Return Report & Fast Entry and Exit Trade Plans - khodrobank.com
Is EyePoint Pharmaceuticals (NASDAQ:EYPT) In A Good Position To Invest In Growth? - Yahoo Finance
Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Why is EyePoint Pharmaceuticals Inc stock going upSell Signal & Growth Oriented Trading Recommendations - khodrobank.com
Resistance Check: Should I invest in EyePoint Pharmaceuticals Inc. before earningsWeekly Earnings Recap & Stock Timing and Entry Methods - khodrobank.com
US Market Wrap: Why is EyePoint Pharmaceuticals Inc stock going up2025 Key Lessons & Real-Time Buy Signal Notifications - khodrobank.com
Dynamic Technology Lab Private Ltd Grows Holdings in Eyepoint Pharmaceuticals, Inc. $EYPT - MarketBeat
Buybacks Report: Does PROG Holdings Inc align with a passive investing strategy2025 Momentum Check & Short-Term Swing Trade Alerts - خودرو بانک
Stop Loss: Can EyePoint Pharmaceuticals Inc. reach resistance levels soonEarnings Summary Report & Risk Controlled Swing Alerts - khodrobank.com
Rate Hike: What are analysts price targets for EyePoint Pharmaceuticals IncJuly 2025 Price Swings & AI Optimized Trading Strategy Guides - khodrobank.com
Gains Report: Should I trade or invest in EyePoint Pharmaceuticals IncJuly 2025 Technicals & Weekly Market Pulse Alerts - خودرو بانک
EyePoint (EYPT) Awards Stock Options to New Employees as Inducem - GuruFocus
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire
S P Trends: What is CWENs 5 year growth outlook2025 Earnings Impact & Capital Efficient Trading Techniques - خودرو بانک
Aug Volume: Is EyePoint Pharmaceuticals Inc stock forming a triangle patternWeekly Profit Report & Safe Capital Preservation Plans - khodrobank.com
Price Action: Is EyePoint Pharmaceuticals Inc. stock overvalued or fairly pricedWeekly Risk Summary & AI Powered Trade Plan Recommendations - khodrobank.com
Eyepoint Pharmaceuticals (NASDAQ:EYPT) Shares Down 4.4%What's Next? - MarketBeat
Eyepoint Pharmaceuticals, Inc. $EYPT Shares Purchased by Invesco Ltd. - MarketBeat
Eyepoint Pharmaceuticals (NASDAQ:EYPT) Sets New 1-Year HighTime to Buy? - MarketBeat
American Century Companies Inc. Acquires Shares of 42,860 Eyepoint Pharmaceuticals, Inc. $EYPT - MarketBeat
Walleye Capital LLC Acquires New Shares in Eyepoint Pharmaceuticals, Inc. $EYPT - MarketBeat
Eyepoint Pharmaceuticals, Inc. $EYPT Position Raised by Adage Capital Partners GP L.L.C. - MarketBeat
Is EyePoint Pharmaceuticals Inc. in Accumulation Phase NowJuly 2025 Setups & High Return Stock Watch Alerts - beatles.ru
Will EyePoint Pharmaceuticals Inc. stock recover after recent drop2025 Market Sentiment & Free Reliable Trade Execution Plans - Newser
Evaluating EyePoint Pharmaceuticals Inc. with trendline analysisMarket Weekly Review & Daily Growth Stock Investment Tips - Newser
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Looks Just Right With A 32% Price Jump - simplywall.st
What is the next catalyst for EyePoint Pharmaceuticals Inc.2025 Biggest Moves & Fast Moving Stock Trade Plans - khodrobank.com
Can EyePoint Pharmaceuticals Inc. outperform under higher oil pricesQuarterly Portfolio Report & Fast Gain Stock Tips - خودرو بانک
Using economic indicators to assess EyePoint Pharmaceuticals Inc. potential2025 Momentum Check & Fast Gain Stock Tips - Newser
What’s EyePoint Pharmaceuticals Inc.’s historical returnWeekly Investment Recap & Free Safe Entry Trade Signal Reports - خودرو بانک
What is EyePoint Pharmaceuticals Inc.’s market positionWeekly Profit Analysis & Community Verified Trade Signals - خودرو بانک
Applying Wyckoff theory to EyePoint Pharmaceuticals Inc. stockJuly 2025 PreEarnings & Precise Swing Trade Entry Alerts - Newser
What is the PEG ratio of EyePoint Pharmaceuticals Inc.July 2025 Spike Watch & Smart Investment Allocation Insights - khodrobank.com
Can EyePoint Pharmaceuticals Inc. lead its sector in growthJuly 2025 Update & Real-Time Price Movement Reports - خودرو بانک
Analyzing drawdowns of EyePoint Pharmaceuticals Inc. with statistical toolsWeekly Trading Summary & Daily Growth Stock Investment Tips - Newser
What to expect from EyePoint Pharmaceuticals Inc. in the next 30 daysQuarterly Earnings Summary & Reliable Intraday Trade Alerts - Newser
What technical models suggest about EyePoint Pharmaceuticals Inc.’s comebackWeekly Gains Report & Weekly Watchlist for Hot Stocks - Newser
Will EyePoint Pharmaceuticals Inc. see short term momentumJuly 2025 Review & Low Drawdown Trading Strategies - Newser
Technical analysis overview for EyePoint Pharmaceuticals Inc. stockJuly 2025 Update & Verified Momentum Watchlists - Newser
Eyepoint Pharmaceuticals, Inc. $EYPT Stake Boosted by Wellington Management Group LLP - MarketBeat
How to integrate EyePoint Pharmaceuticals Inc. into portfolio analysis toolsEarnings Miss & AI Driven Stock Price Forecasts - Newser
Can EyePoint Pharmaceuticals Inc. reach resistance levels soonSell Signal & Trade Opportunity Analysis - خودرو بانک
How to recover losses in EyePoint Pharmaceuticals Inc. stockBreakout Watch & Low Risk High Win Rate Picks - Newser
Multi factor analysis applied to EyePoint Pharmaceuticals Inc.July 2025 Selloffs & Verified Entry Point Detection - Newser
Volatility clustering patterns for EyePoint Pharmaceuticals Inc.Trade Risk Assessment & Long-Term Safe Return Strategies - Newser
Vanguard Group Inc. Has $20.78 Million Stock Holdings in Eyepoint Pharmaceuticals, Inc. $EYPT - MarketBeat
Can a trend reversal in EyePoint Pharmaceuticals Inc. lead to recoverySell Signal & Weekly Return Optimization Plans - Newser
Is now a turning point for EyePoint Pharmaceuticals Inc.Quarterly Portfolio Review & Breakout Confirmation Trade Signals - Newser
News impact scoring models applied to EyePoint Pharmaceuticals Inc.2025 Dividend Review & Free Community Consensus Stock Picks - Newser
Should I average down on EyePoint Pharmaceuticals Inc. stockInsider Selling & Verified Short-Term Trading Plans - خودرو بانک
Eyepoint Pharmaceuticals Inc Azioni (EYPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.43%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):